President Donald Trump’s approval rating improved in two polls this week, declined in three and was stagnant in another—hovering at around 40%, similar to his historically low rating at this point ...
The FDA has approved the first ever RNA interference drug – Alnylam’s Onpattro (patisiran) for the nerve damage caused by the rare disease hereditary transthyretin-mediated amyloidosis (hATTR) in ...
The Rasmussen Reports daily Presidential Tracking Poll for Tuesday shows that 43% of Likely U.S. Voters approve of President Trump’s job performance. Fifty-six (56%) disapprove. The latest figures ...
Where's the best place to learn about life?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results